According to the report, the Plasma Protein Therapeutics market is predicted to achieve USD 31,976 million by 2026. This report examines the status quo and projections of the global Plasma Protein Therapeutics market and analyzes the Plasma Protein Therapeutics market by manufacturer, type, application, and region. This report focuses on top manufacturers in North America, Europe, Japan, China, India, Southeast Asia, and other regions (Central and South America, Middle East and Africa).
Plasma is the liquid parts of blood that residue once platelets, white and red blood cells and various other cellular components are detached. In human blood, only plasma is the largest component and contains proteins, antibodies, enzymes, salts, and water. Plasma is the protein-rich fluids that defer cells in human blood and achieves various essential transport functions. The proteins that originate in plasma plays an important function in clotting and provide immunity to diseases. Plasma proteins are used in many conditions for treatment such as shocks & burns, neurological & bleeding disorders, autoimmune and immune deficiencies. Plasma protein therapies is a unique biological medicine which contains biological starting material called plasma which has a unique biochemical profile which differs in processing methods and production methods. Plasma protein therapies are used to treat various genetic, chronic, life-threatening and rare diseases.
The Plasma Protein Therapeutics market report covers the leading players in the market and analyzes their key strategies. Leading players in this market include CSL Behring, Octapharma USA, Inc., Grifols, S.A., China Biologic Products Holdings, Inc., Biotest AG, Kedrion S.P.A. \, Baxter International, HuaLan BIO, Benesis Corporation, Baxalta, etc.
The prominent market players maintain the competitive edge in the global market by making investments in the mergers and acquisitions and by increasing their product portfolio.
Get FREE Sample of Plasma Protein Therapeutics Market Report at:
It is estimated that the total market value of the Plasma Protein Therapeutics global market is poised to reach USD 31,976 million in 2026 from USD 22,634 million in 2019, with a CAGR of 5.06%.
Facilitating and Limiting Factors:
The Plasma Protein Therapeutics market is expected to register substantial growth in the coming years, owing to an increasing geriatric population and the high prevalence of bleeding and other rare disorders. In addition, increasing R & D activities and high demand for advanced therapeutic options are also positively influencing the market growth. Introduction of new plasma-derived therapies is one of the key trends that will contribute to the growth of this market in the coming years. Yet, stringent regulations and lack of proper reimbursement policies will impede the growth of the market.
The global Plasma Protein Therapeutics market is broadly divided based on type, application, and region:
By type – Coagulation Factors, Immunoglobulins, Albumins, C1 esterase Inhibitors
The Immunoglobulins segment held the major market in 2018. The demand for Immunoglobulins is expected to increase due to the prevalence of primary immunodeficiencies, usage in new indications, and ease of administration.
By application – Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency (CLL, multiple myeloma, congenital aids), Hereditary Angioedema, Others
Plasma Protein Therapeutics is increasingly used in the treatment of primary immunodeficiency disorder. The Primary Immunodeficiency Disorder segment is expected to register a CAGR of 6.32% during the forecast period.
By region – North America, Asia-Pacific, Europe, Latin America, Middle East, and Africa, Others
In 2018, the Plasma Protein Therapeutics global market was mainly concentrated in the three regions of North America, Europe, and Asia-Pacific. North America is the largest market at a share of 32.54%, followed by Europe and Asia-Pacific, accounting for 29.19% and 26.84% respectively. The presence of a large patient base and growing geriatric population are contributing to the growth of the market in the North America region. In addition, increased adoption of novel therapeutics and rising disease prevalence are also projected to fuel the expansion of this regional market. Asia-Pacific is anticipated to witness high growth in the forthcoming years, owing to increasing healthcare expenditure and the presence of a large number of patients in this region.
Purchase a copy of Plasma Protein Therapeutics report at:
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Plasma Protein Therapeutics Market
2 Market Trends and Competitive Landscape
3 Segmentation of Plasma Protein Therapeutics Market by Types
4 Segmentation of Plasma Protein Therapeutics Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Plasma Protein Therapeutics Market in Major Countries
7 North America Plasma Protein Therapeutics Landscape Analysis
8 Europe Plasma Protein Therapeutics Landscape Analysis
9 Asia Pacific Plasma Protein Therapeutics Landscape Analysis
10 Latin America, Middle East & Africa Plasma Protein Therapeutics Landscape Analysis
11 Major Players Profile
11.1 CSL Behring
11.1.1 CSL Behring Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Octapharma USA, Inc.
11.3 Grifols, S.A.
11.4 China Biologic Products Holdings, Inc.
11.5 Biotest AG
11.6 Kedrion S.P.A. \
11.7 Baxter International
11.8 HuaLan BIO
11.9 Benesis Corporation
- Plasma Protein Therapeutics manufacturers
- Plasma Protein Therapeutics importers and exporters
- Plasma Protein Therapeutics traders, distributors, and suppliers
- Plasma Protein Therapeutics industry associations
- Product managers, Plasma Protein Therapeutics industry administrator, C-level executives of the industries
- Market Research and consulting firms
- Healthcare organizations
- Research & Clinical Laboratories
What Information does this report contain?
- The report covers the prediction and analysis of the global Plasma Protein Therapeutics market at the global and regional levels.
- The report includes drivers and constraints that affect market growth.
- Discussed details about market opportunities
- The assessments for the regional market layout characteristics in the world.
- The report includes detailed company profiles for prominent market participants.
Ask for a discount at:
Global Market Monitor is a company that provides comprehensive services and products to global clients. We regularly update new reports on the website, ensuring that our clients stay abreast of the latest trends in their industries.
We engage in a wide, diverse range of international businesses and have established a sound customer base with about 11,000 clients in over 102 countries and regions. Headquartered in the USA and with 6 global offices around the world, it is convenient for Global Market Monitor to get a global view for global clients.
We are always committed to delivering customized market research solutions with the highest quality. As an information service company, we are specialized in offering market intelligence services from more than 500 research institute, involving plenty of industries, companies, trends, market drivers and other strategic data. About 100 million statistics with tables, figures and datasets are easy to access. Reports provided by Global Market Monitor can reveal the interrelationship between industries and markets so that our clients have a better understanding of the global economy, risk, opportunity, and financial impact.
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Web Site: https://www.globalmarketmonitor.com